tykhr
sign in
free sign up
InMed Pharmaceuticals Inc
Drug Manufacturers - Specialty & Generic
Healthcare
INM
10.96 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
2.25
52 week high
7.10
high
2.30
52 week low
0.00
low
2.11
growth
-59.62 %
previous Close
2.27
P/E ratio
-1
market cap
4.18 M
div yield
0
usd
Mar 2025
qoq
revenue
1.26 B
13.48 %
net incoming
-2.12 B
17.63 %
eps
-1.94 %
46.90 %
eps surprise
0.00 %
net profit margin
-168.12 %
63.00 %
operating incoming
-2.06 B
4.18 %
net change in cash
4.68 B
216.00 %
cash on hand
4.68 B
136.00 %
cost of revenue
1.09 B
66.86 %
top